Extract from the Register of European Patents

EP About this file: EP2883957

EP2883957 - Immunostimmulatory oligoribonucleotides [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.05.2016
Database last updated on 26.03.2026
Most recent event   Tooltip13.05.2016Application deemed to be withdrawnpublished on 15.06.2016  [2016/24]
Applicant(s)For all designated states
Zoetis Belgium S.A.
1, Rue Laid Burniat
1348 Louvain-la-Neuve / BE
[2015/25]
Inventor(s)01 / Forsbach, Alexandra
Am Alten Broich 219
40764 Langenfeld / DE
02 / Vollmer, Joerg
Flemingweg 15
40591 Dusseldorf / DE
03 / Lipford, Grayson
20 Watertown Street
Unit 127
Watertown, MA 02472-2586 / US
 [2015/25]
Representative(s)Mannion, Sally Kim
Zoetis
European Patent Department
Walton Oaks, Dorking Road
Tadworth
Surrey KT20 7NS / GB
[2015/25]
Application number, filing date15150854.622.11.2006
[2015/25]
Priority number, dateUS20050739529P25.11.2005         Original published format: US 739529 P
US20060778989P03.03.2006         Original published format: US 778989 P
[2015/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2883957
Date:17.06.2015
Language:EN
[2015/25]
Search report(s)(Supplementary) European search report - dispatched on:EP18.05.2015
ClassificationIPC:C12N15/117, A61K31/7105, // A61P31/00, A61P35/00, A61P37/04
[2015/25]
CPC:
A61K39/39 (EP,US); C12N15/117 (EP,KR,US); A61K31/7105 (EP,KR,US);
A61K9/127 (KR); A61P11/06 (EP); A61P31/00 (EP);
A61P31/04 (EP); A61P31/12 (EP); A61P31/14 (EP);
A61P31/20 (EP); A61P35/00 (EP); A61P37/02 (EP);
A61P37/04 (EP); A61P37/06 (EP); A61P37/08 (EP);
A61P43/00 (EP); A61K2039/55561 (EP,US); C12N2310/17 (EP,US);
C12N2310/315 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/25]
TitleGerman:Immunstimulierende Oligoribonukleotide[2015/25]
English:Immunostimmulatory oligoribonucleotides[2015/25]
French:Oligoribonucleotides immunostimulateurs[2015/25]
Examination procedure12.01.2015Examination requested  [2015/25]
18.12.2015Application deemed to be withdrawn, date of legal effect  [2016/24]
25.01.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2016/24]
Parent application(s)   TooltipEP06838257.1  / EP1957647
Fees paidRenewal fee
12.01.2015Renewal fee patent year 03
12.01.2015Renewal fee patent year 04
12.01.2015Renewal fee patent year 05
12.01.2015Renewal fee patent year 06
12.01.2015Renewal fee patent year 07
12.01.2015Renewal fee patent year 08
12.01.2015Renewal fee patent year 09
06.11.2015Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I] WO03086280  (COLEY PHARM GMBH et al.)
 [A] WO2005097993  (COLEY PHARM GROUP INC et al.)
 [A]   HEIL F ET AL: "Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 303, 5 March 2004 (2004-03-05), pages 1526 - 1529, XP002358689, ISSN: 0036-8075

DOI:   http://dx.doi.org/10.1126/science.1093620
 [A]   GORDEN KEITH B ET AL: "Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, vol. 174, no. 3, 1 February 2005 (2005-02-01), pages 1259 - 1268, XP009163641, ISSN: 0022-1767

DOI:   http://dx.doi.org/10.4049/jimmunol.174.3.1259
 [A]   DIEBOLD S ET AL: "Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 303, 5 March 2004 (2004-03-05), pages 1529 - 1531, XP002358690, ISSN: 0036-8075, DOI: 10.1126/SCIENCE.1093616

DOI:   http://dx.doi.org/10.1126/science.1093616
by applicantUS6849725
 US6194388
 US6207646
 US6214806
 US6218371
 US6239116
 US6339068
 WO0122990
 US2003148976
 WO9524929
 WO9703702
 US5075109
 US4452775
 US4675189
 US5736152
 US3854480
 US5133974
 US5407686
   MEDZHITOV R ET AL., MOL CELL, vol. 2, 1998, pages 253 - 8
   ADEREM A ET AL., NATURE, vol. 406, 2000, pages 782 - 87
   AKIRA S ET AL., NAT REV IMMUNOL, vol. 4, 2004, pages 499 - 511
   YOSHIMURA A ET AL., J IMMUNOL, vol. 163, 1999, pages 1 - 5
   ALIPRANTIS AO ET AL., SCIENCE, vol. 285, 1999, pages 736 - 9
   POLTORAK A ET AL., SCIENCE, vol. 282, 1998, pages 2085 - 8
   HOSHINO K, J IMMUNOL, vol. 162, 1999, pages 3749 - 52
   HAYASHI F ET AL., NATURE, vol. 410, 2001, pages 1099 - 1103
   OZINSKY A ET AL., PROC NATL ACAD SCI USA, vol. 97, 2000, pages 13766 - 71
   TAKEUCHI 0 ET AL., INT IMMUNOL, vol. 13, 2001, pages 933 - 40
   HEN H ET AL., NAT FINMUNOL, vol. 3, 2002, pages 1 96 - 200
   JURK M ET AL., NAT IMMUNOL, vol. 3, 2002, pages 499
   HEMMI H ET AL., NATURE, vol. 408, 2000, pages 740 - 5
   BAUER S ET AL., PROC NATL ACAD SCI USA, vol. 98, 2001, pages 9237 - 42
   PENG G ET AL., SCIENCE, vol. 309, 2005, pages 1380 - 4
   NIELSEN P ET AL., CHEMISTRY-A EUROPEAN JOURNAL, vol. 8, 2002, pages 712 - 22
   VANDENDRIESSCHE ET AL., TETRAHEDRON, vol. 49, 1993, pages 7223
   TARKOV M ET AL., HELV CHIM ACTA, vol. 76, 1993, pages 481
   GREGORIADIS G, TRENDS BIOTECHNOL, vol. 3, 1985, pages 235 - 241
   BEAUCAGE SL ET AL., TETRAHEDRON LETT, vol. 22, 1981, pages 1859
   GAREGG P ET AL., TETRAHEDRON LETT, vol. 27, 1986, pages 4051 - 4
   FROEHLER BC ET AL., NUCL ACID RES, vol. 14, 1986, pages 5399 - 407
   GAREGG P ET AL., TETRAHEDRON LETT, vol. 27, 1986, pages 4055 - 8
   GAFFNEY BL ET AL., TETRAHEDRON LETT, vol. 29, 1988, pages 2619 - 22
   UHLMANN E ET AL., CHEM REV, vol. 90, 1990, pages 544 - 84
   GOODCHILD J, BIOCONJUGATE CHERN, vol. 1, 1990, pages 165
   MATTEUCCI; CARUTHERS; MATTEUCCI MD ET AL., JAM CHERN SOC, vol. 103, 1981, pages 3185
   ALAZZOUZI ET AL., NUCLEOSIDES NUCLEOTIDES, vol. 16, 1997, pages 1513 - 14
   C.G.A THOMAS: "Medical Microbiology", 1983, BAILLIERE TINDALL
   COHEN PA ET AL., CANCER RES, vol. 54, 1994, pages 1055 - 8
   BAMES; PETERSON, AM REV RESPIR DIS, vol. 148, 1993, pages 81 - 826
   KAMADA AK ET AL., AM J RESPI CRIT CARE MED, vol. 153, 1996, pages 1739 - 48
   DJUKANOVIC R ET AL., AM REV RESPIR DIS, vol. 142, 1990, pages 434 - 457
   ROBINSON DS ET AL., N ENG J MED, vol. 326, 1992, pages 298 - 304
   FRALEY ET AL., TRENDS BIOCHEM SCI, vol. 6, 1981, pages 77
   CHICKERING ET AL., BIOTECH BIOENG, vol. 52, 1996, pages 96 - 101
   MATHIOWITZ E ET AL., NATURE, vol. 386, 1997, pages 410 - 414
   H.S. SAWHNEY; C.P. PATHAK; J.A. HUBELL, MACROMO ECU ES, vol. 26, 1993, pages 581 - 587
   LANGER R, SCIENCE, vol. 249, 1990, pages 1527 - 1533
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.